Human monoclonal antibody development
“30+ years’ experience” “Innovative, scientific, interactive and customer-centric services”Development of human monoclonal antibodies by EBV transformation of PBMCs or B cells from convalescent blood.
In 2020-21, Bioklone Biotech Private Limited received funding under strategic funding for Covid-19 consortium under National Biopharma Mission for “Development of human monoclonal antibodies to SARS-CoV-2 from convalescent patient blood”. https://birac.nic.in/nbm/cms/page/therapeutic-strategies-for-COVID